by Biospring | Apr 26, 2022 | Amazon, Biospring Partners, CIC Health, COVID-19, Health Care, Maulik Majmudar, Rodrigo Martinez, Telehealth, Vaccines
We recently hosted a discussion with Dr. Maulik Majmudar, Cardiologist and Principal Medical Officer at Amazon and Rodrigo Martinez, Chief Marketing and Experience Officer at CIC Health. Maulik and Rodrigo shared their unique perspective on how healthcare has changed... 
by Biospring | Apr 26, 2022 | Astrazeneca, Biospring Partners, COVID-19, Economy, Jay Bradner, Katie Burke, Novartis, Oxford, Peter B. Henry, Return to work, Sir John Bell, Vaccines
Last December, we hosted a discussion with industry leaders on COVID-19 and Vaccines, Return-to-Work, and the Economy. We were delighted to host Dr. Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Biospring’s advisors Sir... 
by Biospring | Apr 25, 2022 | Abzena, Biologics, Biotech, CDMO, COVID-19, Drug Development, Drug Discovery, Drug Manufacturing, Pharma, Sven Lee
We shared an overview on Abzena following our investment in July. Over the past few months, Abzena has launched a new facility in San Diego and has made several executive hires. We recently spoke with Sven Lee, Chief Business Officer at Abzena, and he provided us with... 
by Biospring | Apr 25, 2022 | Concentric, COVID-19, DNA, Ginkgo Bioworks, Jason Kelly, Synbio, Synthetic Biology
Ginkgo Bioworks is using its synthetic biology platform in the fight against the pandemic. We asked Jason Kelly, CEO of Ginkgo Bioworks, to update us on Concentric, a program that offers COVID-19 testing at scale to support schools and businesses in their reopening...
